Category: News

Sartar Therapeutics is presenting at the Showcase Biotech stage on 3rd May at 15:30. Come and see us or book a meeting during the event! LSX Congress 3-4 May, Business Design Center, London, UK.

We are pleased to announce that Sartar Therapeutics has been granted orphan drug designation in EU by the European Commission. See more on Community Register of orphan medicinal products.

Maria Lahtinen has been appointed to the role of Quality Director since 1st Jan 2023 to support the company growth and transfer from preclinical to clinical stage. Maria has a long pharma experience in various drug development activities from laboratory to clinics in companies of various sizes. At Sartar her main responsiblity is to develop […]

Sartar Therapeutics is strengthening its board with two new board members, Jyrki Mattila and Jami Mandelin, who will bring decades of experience in the biotech industry and healthcare business to the company. Jyrki Mattila’s career in the pharma & biotech space spans for over forty years in Europe and in the U.S. Prior to moving to the […]

Sartar Therapeutics was featured on Dutch TV channel RTL7 in their program Business in Europe! Great visibility and acknowledgement to our work for soft tissue sarcomas.

Sartar was selected to present at the Anglonordic Life Science Conference held at the County Hall in London on 5th May 2022. The event gathers European investors and R&D companies from the Nordics and the UK to connect with each other. In addition to the presenting companies, the program focused on the current trends in […]

Sartar participated the NOME Annual Meeting on 23rd Nov 2021 in Copenhagen, meeting mentors and other life science and medtech startups. NOME is an elite Nordic Mentoring Program that matches selected Nordic startups with highly skilled professionals to help them reach their goals and technology milestones. Sartar was selected to the program last June and has […]

Sartar Therapeutics was selected to NOME (Nordic Mentor Network for Entrepreneurship), an elite Nordic Mentoring program that connects most promising life science startups with highly skilled relevant professionals to help them reach their goals and technology milestones. We had our first mentoring session with lots of valuable insights and are eager to continue the journey […]

We are proud to inform that the national innovation funding body Business Finland has granted R&D funding for Sartar Therapeutics. This R&D loan will allow us to advance the development of our product SAR001 towards clinical trials. We consider this positive decision as a significant credit for our technology for the treatment of soft tissue sarcomas.

We are happy to announce Mikael Maksimow has joined our team as a COO. Welcome Mikael! Mikael has broad experience in drug development from innovations to international clinical trials. His experience in advancing start-up companies will be a great addition to our small but efficient team.